Evolut FX TAVR System Adds Innovative Features to Enhance Ease-of-Use and Predictable Valve Deployment
September 26, 2022
Medtronic Announces FDA Approval of Next-Gen TAVR System for Treatment of Symptomatic Severe Aortic Stenosis
September 26, 2022 — Medtronic plc, a global leader in medical technology, announced U.S. Food and Drug Administration…
Read More
Study of the Paradise Ultrasound Renal Denervation System Shows Significant Reduction in Blood Pressure in Patients with Uncontrolled Hypertension
September 26, 2022
ReCor Medical Announces Results of RADIANCE II Pivotal Trial at TCT 2022 Annual Meeting
September 26, 2022 — ReCor Medical, Inc., a wholly owned subsidiary of Otsuka Medical Devices Co., Ltd., announced the…
Read More
Avicenna.AI are a medical imaging AI developer, optimizing radiologists’ manual tasks and identifying acute abnormalities. This partnership involves their stroke product suite, which enables automatic identification and triage for acute stroke.
September 22, 2022
Avicenna.AI Partners With deepc to Revolutionize Stroke Patient Care
September 22, 2022 — Medical imaging specialist Avicenna.AI announced a groundbreaking partnership with the MedTech…
Read More
Abiomed (ABMD) announces the result of a three-year, investigator-led study of all Impella-supported patients treated at 109 hospitals in Japan shows a 30-day survival rate of 77% for patients with cardiogenic shock due to myocarditis.
September 22, 2022
Multi-Center, Multi-Society Study of Impella-supported Patients with Cardiogenic Shock due to Myocarditis in Japan Achieves 30-day Survival of 77%
September 22, 2022 — Abiomed (ABMD) announces the result of a three-year, investigator-led study of all Impella-…
Read More
David J. Cohen, MD, MSc, St. Francis Hospital and CRF, presented Jennifer A. Rymer, MD, Duke University Medical Center with the TCT 2022 Thomas J. Linnemeier Young Investigator Award, along with co-presenter Gary S. Mintz of the Cardiovascular Research Foundation (CRF) on Sept 19 in Boston, MA.
September 22, 2022
TCT 2022 Honors Recipient of Thomas J. Linnemeier Young Investigator Award
September 22, 2022 — The recipient of the TCT 2022 Thomas J. Linnemeier “Spirit of Interventional Cardiology” Young…
Read More
September 21, 2022
Medtronic Receives FDA Indication for Bifurcation Percutaneous Coronary Intervention with a Drug-eluting Stent
September 21, 2022 — Medtronic announced today that it has received Food and Drug Administration (FDA) approval for the…
Read More
EMPOWER CAD is the First Prospective, Female-Only Study of Coronary Interventions
September 21, 2022
Shockwave Medical Initiates All-Female Coronary IVL Study
September 21, 2022 — Shockwave Medical, Inc., a pioneer in the development of Intravascular Lithotripsy (IVL) to treat…
Read More
Over the 10-year span, median cardiology compensation – regardless of ownership model – increased (Figure 1). From 2011 to 2021, private cardiology compensation expanded by 32% to a median of $604,652 per FTE, and integrated cardiology income increased by 13% to $621,596 per FTE.
September 21, 2022
Cardiology Compensation and New Patient Visits Rebound, Survey Finds
September 21, 2022 — MedAxiom, the premier source for cardiovascular organizational performance solutions, has released…
Read More
Statistically significant mean reductions of 10.3 mmHg in 24-hour ambulatory systolic blood pressure and 11.7 mmHg in ambulatory pulse pressure after 6 months of therapy in control patients who crossed over to BackBeat CNT following completion of the randomized portion of the MODERATO II study
September 20, 2022
Orchestra BioMed Announces Presentation of Positive Long-Term Clinical Results from MODERATO II Control Patients Crossover Extension Study of BackBeat CNT at TCT 2022
September 20, 2022 — Orchestra BioMed, Inc., a biomedical innovation company accelerating high-impact technologies to…
Read More
The LINQ II ICM is the first continuous, long-term cardiac monitor cleared by FDA for the pediatric patient population
September 20, 2022
Medtronic Receives FDA Clearance for Expanded Indication of LINQ II Insertable Cardiac Monitor For Use in Pediatric Patients Ages 2 and Older
September 20, 2022 — Medtronic, a global leader in healthcare technology, today announced the LINQ II Insertable…
Read More
Results of the CLASP IID Trial Presented at TCT and published simultaneously in JACC: Cardiovascular Interventions
September 20, 2022
Novel TEER Repair Device Meets Primary Endpoint in Treating Degenerative Mitral Regurgitation in Patients Not Eligible for Surgery
September 20, 2022 — Results of the first randomized controlled trial to directly compare two contemporary…
Read More
Results from TVT registry analysis presented at TCT and published simultaneously in the Journal of the American College of Cardiology
September 20, 2022
STS/ACC TVT Registry Analysis Assesses Use of Transcatheter Edge-to-Edge Repair in Severe Mitral Regurgitation and Cardiogenic Shock
September 20, 2022 —  An analysis from the Society of Thoracic Surgeons/American College of Cardiology(STS/ACC) TVT…
Read More
The TCT 2022 Innovation Shark Tank Competition award presentation was held Sept. 19, in Boston, MA. Shown here announcing the winner, Puzzle Medical Devices, are Robert Schwartz, MD, and Juan F. Granada, President and CEO of the Cardiovascular Research Foundation (CRF).
September 20, 2022
TCT 2022 Announces Winner of Shark Tank Innovation Award
September 19, 2022 — Puzzle Medical Devices, a provider of hemodynamic support in Heart Failure (HF), was selected as…
Read More
FIH study demonstrated feasibility and safety of cardiorenal support among patients undergoing high-risk PCI
September 19, 2022
First-in-Human Study Finds Mechanical Circulatory Support and Renal Perfusion Success with the ModulHeart Device
September 19, 2022 —  A first-in-human (FIH) study using the ModulHeart device (Puzzle Medical Devices Inc.) has…
Read More
Patent Opens Pathway to a Disruptive Ischemia and Arrhythmia Detection ECG Patch Product
September 19, 2022
HeartBeam Granted Patent for 12-Lead Electrocardiogram (ECG) Patch Monitor Intended for Detection of Heart Attacks and Complex Cardiac Arrhythmias
September 19, 2022 —  HeartBeam, Inc. (NASDAQ: BEAT), a cardiac technology company that has developed the first and…
Read More
Dr. Gagan Singh, Dr. Susheel Kodali, and Dr. Azeem Latib with principal investigator, Dr. Adrian Ebner, following the initial first-in-human cases with the Supira System.
September 19, 2022
Supira Medical Announces Successful First-in-Human Use of its Next Generation Percutaneous Ventricular Assist Device
September 19, 2022 —  Supira Medical, Inc., a Shifamed portfolio company focused on developing the next-generation…
Read More
Results also demonstrate the benefits for patients of Abbott's TriClip™ for tricuspid regurgitation, Amulet™ for atrial fibrillation and Portico™ for aortic stenosis
September 17, 2022
Late-Breaking Data Show Breadth of Abbott's Minimally Invasive Structural Heart Technologies
September 17, 2022 — Abbott today announced data from five late-breaking presentations showing the benefits of its…
Read More
Pathological Findings Confirm Importance of Early Detection and Treatment of Thrombus on Valve Leaflets
September 17, 2022
First-ever Comparison of MicroCT and Histology in Self-expanding Transcatheter Aortic Valve Replacement Patients with Hypo-attenuated Leaflet Thickening
September 17, 2022 — Medtronic today announced findings from its Pathological Study of Hypo-Attenuated Leaflet…
Read More
The Impella CP with SmartAssist heart pump is a minimally invasive, temporary heart pump that uses real-time intelligence associated with improved survival and heart recovery. (Graphic: Business Wire)
September 17, 2022
Unloading with Impella for 30 Minutes Before PCI Associated with Reduced Infarct Size in STEMI Patients
September 17, 2022 — Results of a new per-protocol analysis of the ST-segment Elevation Myocardial Infarction Door-To-…
Read More
Results from largest randomized TAVR trial to date presented at TCT 2022
September 17, 2022
Late-Breaking Data from PROTECTED TAVR Trial Demonstrate Reduced Risk of Disabling Stroke, Low Complication Rate with SENTINEL Cerebral Protection System
September 17, 2022 —  Boston Scientific Corporation has announced results from the PROTECTED TAVR clinical trial…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now